GENE ONLINE|News &
Opinion
Blog

COVID-19
COVID-19 Johnson & Johnson
FDA Limits Use of Johnson & Johnson COVID Vaccine Due to Blood Clot Risks
2022-05-06
COVID-19
Vaccine Inequity, How Pandemic Becomes Endemic
2022-05-03
COVID-19 T-cell
Scientists Jointly Urge FDA to Evaluate T-Cell Response in Review of COVID-19 Vaccines
2022-04-27
COVID-19 COVID-19 Vaccine
Moderna Shares Promising Preliminary Bivalent COVID-19 Booster Results
2022-04-20
Deals Australia
KKR-led Group Attempts $14.8 Billion Takeover of Australia’s Ramsay Health Care
2022-04-19
COVID-19
WHO report highlights the role of Traditional Chinese Medicine in the treatment of COVID-19
2022-04-18
China COVID-19
Fosun Diagnostics Receives China NMPA Approval for Its Independently Developed Novel Coronavirus Antigen Detection Kit
2022-04-16
COVID-19 FDA Approval
FDA Greenlights the First COVID-19 Breath Test
2022-04-15
COVID-19 mRNA Vaccine
Good or Bad: The 4th Dose of mRNA COVID Vaccine
2022-04-12
COVID-19
CUHK Researchers Discover Distinct Gut Microbial Signatures for Prediction, Diagnosis and Treatment of Long COVID
2022-04-11
COVID-19 Oral Drug
EUA of Monoclonal Antibodies Revoked: Are Oral COVID Drugs the Only Hope?
2022-04-06
COVID-19 GoogleFacebook
How Do Tech Giants Like Google and Meta Improve Our Understanding of Public Health During Pandemic
2022-04-06
COVID-19 COVID-19 Treatment
Kintor Pharma’s Proxalutamide Demonstrated Reduction in Hospitalization/Mortality for Patients with Mild to Moderate COVID-19 in Phase III MRCT Study
2022-04-05
COVID-19 COVID-19 Treatment
The Absence of Long COVID Treatment Plans Has Become a New Business Opportunity for Medium-sized Pharmas
2022-03-30
COVID-19 Sinopharm
Brii Bio Announces Strategic Partnership with Sinopharm to Advance Commercialization of Long-Acting COVID-19 Neutralizing Antibody Therapy, Amubarvimab/Romlusevimab Combination, in China
2022-03-29
1 2 3 4 5 6 … 25
LATEST
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top